 |
Journal articles
Neutrophils mediate antibody-induced antitumor effects in mice.
Abstract : Tumor engraftment followed by monoclonal antibody (mAb) therapy targeting tumor antigens represents a gold standard for assessing the efficiency of mAbs to eliminate tumor cells. Mouse models have demonstrated that receptors for the Fc portion of immunoglobulin G (FcγRs) are critical determinants of mAb therapeutic efficacy, but the FcγR-expressing cell populations responsible remain elusive. We show that neutrophils are responsible for mAb-induced therapy of both subcutaneous syngeneic melanoma and human breast cancer xenografts. mAb-induced tumor reduction, abolished in neutropenic mice, could be restored in FcγR-deficient hosts upon transfer of FcγR+ neutrophils or upon human FcγRIIA/CD32A transgenic expression. Finally, conditional knockout mice unable to perform FcγR-mediated activation and phagocytosis specifically in neutrophils were resistant to mAb-induced therapy. Our work suggests that neutrophils are necessary and sufficient for mAb-induced therapy of subcutaneous tumors, and represent a new and critical focal point for optimizing mAb-induced immunotherapies that will impact on human cancer treatment.
https://hal-pasteur.archives-ouvertes.fr/pasteur-02513290
Contributor : Marie Martin <>
Submitted on : Friday, March 20, 2020 - 2:42:43 PM
Last modification on : Wednesday, December 9, 2020 - 3:44:35 AM
Contributor : Marie Martin <>
Submitted on : Friday, March 20, 2020 - 2:42:43 PM
Last modification on : Wednesday, December 9, 2020 - 3:44:35 AM
Links full text
